tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH) and Axsome Therapeutics (AXSM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNHResearch Report) and Axsome Therapeutics (AXSMResearch Report) with bullish sentiments.

UnitedHealth (UNH)

In a report issued on March 1, Ann Hynes from Mizuho Securities maintained a Buy rating on UnitedHealth, with a price target of $550.00. The company’s shares closed last Friday at $498.65, close to its 52-week high of $509.23.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 12.0% and a 66.1% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Acadia Healthcare, AmerisourceBergen, and Molina Healthcare.

UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $535.78, which is an 11.5% upside from current levels. In a report issued on February 25, Wells Fargo also maintained a Buy rating on the stock with a $565.00 price target.

See today’s best-performing stocks on TipRanks >>

Axsome Therapeutics (AXSM)

Mizuho Securities analyst Vamil Divan maintained a Buy rating on Axsome Therapeutics on March 2 and set a price target of $51.00. The company’s shares closed last Friday at $29.91.

According to TipRanks.com, Divan has 0 stars on 0-5 stars ranking scale with an average return of -3.4% and a 45.7% success rate. Divan covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, ACADIA Pharmaceuticals, and Xeris Pharmaceuticals.

Currently, the analyst consensus on Axsome Therapeutics is a Strong Buy with an average price target of $84.80, representing a 182.2% upside. In a report issued on March 1, Leerink Partners also maintained a Buy rating on the stock with a $50.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on UNH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed